Market Cap: $128.84B
Market Cap: $128.84B

Medtronic plc ( MDT ) continues to position itself as a leader in healthcare technology through its commitment to innovation and strategic partnerships, bolstered by recent impressive financial perfor…

Medtronic (Ticker: MDT) is gaining significant recognition due to its innovative advancements, particularly with the recent FDA approval of the Symplicity Spyral renal denervation system. This new tec…

Medtronic Plc (Ticker: MDT) achieves a significant milestone with the recent FDA 510(k) clearance for its Nellcor pulse oximetry system. This innovative device incorporates the Nell-EQ intelligent pro…

In recent developments, Medtronic Plc (Ticker: MDT) strengthens its position in the neurovascular market through the acquisition of Scientia Vascular, a company specializing in advanced medical device…

Medtronic Plc (Ticker: MDT) strengthens its leadership in healthcare technology with the recent FDA clearance of its Nellcor pulse oximetry system, now enhanced with the innovative Nell-EQ intelligent…

Medtronic Plc (Ticker: MDT) extends its capabilities in digital health through a renewed partnership with Corsano Health, focusing on a new multi-parameter wearable device. This innovative technology…

Medtronic Plc (Ticker: MDT) is at a crucial turning point in the transcatheter aortic valve replacement (TAVR) market following the positive results of a head-to-head trial between its Evolut valve an…

Medtronic plc (Ticker: MDT) enhances its capabilities in chronic pain management through its acquisition of SPR Therapeutics. This strategic move aims to integrate innovative peripheral nerve stimulat…
Medtronic Plc (Ticker: MDT) unveils significant advancements in medical technology, highlighting the company's strategic focus on innovation. Recently, Medtronic announces key product milestones that…
Medtronic Advances Regulatory Path with Investigational Device Exemption Submission Plans Medtronic Plc announces its plans to submit an Investigational Device Exemption (IDE) application to the U.S.…
Medtronic's Focus on Innovation Amidst Market Volatility In the face of volatile market conditions driven by geopolitical tensions and economic uncertainties, Medtronic Plc emphasizes its commitment t…
Medtronic Enhances Stroke Treatment with Acquisition of Scientia Vascular Medtronic Plc takes a significant step in bolstering its neurovascular portfolio with the announcement of its agreement to acq…
Medtronic Strengthens Neurovascular Portfolio with Scientia Vascular Acquisition In a strategic move to enhance its neurovascular offerings, Medtronic has announced a definitive agreement to acquire S…
Medtronic's Standalone MiniMed: A New Era in Diabetes Management On March 6, 2026, Medtronic plc, a leading player in healthcare technology, announces the initial public offering (IPO) of its subsidia…
### Medtronic’s Commitment to Innovation and Growth Evident through Upcoming MiniMed IPO Medtronic plc, a global leader in healthcare technology based in Galway, Ireland, demonstrates its commitment t…
Medtronic's Financial Strategy Takes Center Stage at Upcoming Investor Conferences Medtronic plc, a global leader in healthcare technology, is set to spotlight its financial strategy with Thierry Piét…
Medtronic to Showcase Leadership at Upcoming Investor Conferences Galway, Ireland - Medtronic plc, a prominent player in the global healthcare technology sector, prepares for two significant investor…
Innovative Diabetes Management: Medtronic Launches the MiniMed Go™ System in Europe Medtronic Plc, a frontrunner in healthcare technology, expands its diabetes management solutions with the launch of…
Medtronic Launches Innovative Diabetes Management Tool in Europe Medtronic Plc has unveiled the MiniMed Go™ Smart MDI system alongside the Simplera™ sensor, marking a significant stride in diabetes ca…
Medtronic posts quarter-beat but leaves metrics unreported Medical device demand and margin drivers under scrutiny Medtronic reports a third-quarter performance that beats expectations, a development…
Medtronic posts modest quarterly beat, highlights operational gains Operational execution drives margin expansion Medtronic Plc is reporting adjusted earnings of $1.36 per share for the quarter, modes…
Medtronic’s operational discipline drives third-quarter outperformance Medtronic Plc is reporting a better-than-expected third quarter, with company statements pointing to resilient end-market demand…
Medtronic moves to acquire CathWorks to expand non‑invasive coronary diagnostics FFRangio acquisition aims to reshape cath lab physiology mapping Medtronic is exercising its option to acquire privatel…
Medtronic to acquire CathWorks, pushing AI diagnostics into cath labs GALWAY, Ireland, Feb. 3 (Reuters) — Medtronic plc announces it will exercise its option to acquire privately held CathWorks, advan…
Medtronic's Growth Prospects Amid Mixed Analyst Ratings Medtronic Plc, a leading player in the medical technology sector, currently navigates a landscape characterized by both optimism and caution fro…
Medtronic's Strategic Push: A New Era of Innovation in Medical Devices Medtronic Plc is entering a promising phase marked by a series of innovative product launches that signal a robust strategic dire…
Medtronic Gears Up for J.P. Morgan Healthcare Conference with Focus on Innovation Medtronic plc, a prominent global healthcare technology enterprise headquartered in Galway, Ireland, prepares to showc…
Medtronic’s Commitment to Innovative Healthcare Solutions Medtronic plc, a leading global healthcare technology company based in Galway, Ireland, reaffirms its commitment to addressing critical health…
Revolutionizing Healthcare: Medtronic's Commitment to AI Integration The medical technology sector is witnessing a remarkable transformation as artificial intelligence (AI) evolves from theoretical co…
Navigating the AI Transformation in Medical Technology The medical technology sector is witnessing a profound transformation as artificial intelligence (AI) shifts from theoretical applications to tan…
Medtronic’s Commitment to AI in Healthcare: Leading the Charge in Medical Technology Innovation The medical technology sector is experiencing a paradigm shift as artificial intelligence (AI) moves fro…
Medtronic Takes Proactive Measures in Catheter Recall Amid Safety Concerns Medtronic Plc has recently informed its customers about the urgent need to remove specific Left Heart Vent Catheters from bot…
Legal Turmoil Shakes Medical Device Sector: Implications for Competitive Practices In the dynamic landscape of the medical device industry, allegations of monopolistic practices create significant rip…
Medtronic Takes Proactive Measures in Catheter Recall Amid Safety Concerns Medtronic Plc is currently addressing a critical safety issue involving its Left Heart Vent Catheters, which are crucial tool…
Medtronic Takes Proactive Measures in Response to Catheter Safety Concerns Medtronic Plc is currently at the forefront of patient safety as it takes decisive action regarding specific Left Heart Vent…
Medtronic's Strategic Shift: Launching MiniMed as a Standalone Entity Medtronic plc, a prominent player in the global healthcare technology industry, announces a significant strategic decision that wi…
Medtronic's MiniMed to Become Independent Entity with Upcoming IPO Medtronic plc, a leading global healthcare technology company, announces a major strategic shift in its operations as it plans to spi…
Ventripoint Diagnostics Partners with Nisg̱a'a Valley Health Authority to Enhance Cardiac Care in Remote Communities Ventripoint Diagnostics Ltd. forges a groundbreaking partnership with the Nisg̱a'a…
Medtronic's Hugo RAS System Secures FDA Clearance, Transforming Urologic Surgery Medtronic Plc makes significant strides in the field of surgical robotics with the recent FDA clearance for its Hugo ro…
Medtronic Embraces a Bullish Outlook Amid Strong Sector Performance In recent developments, Medtronic Plc finds itself positioned within a healthcare sector that exhibits significant momentum. With th…
Senator's Financial Disclosure Highlights Ethical Concerns in Governance In a recent disclosure, Senator Tina Smith reveals a financial transaction involving Huntington Bancshares, valued between $100…
Innovative Leadership in Heart Failure Treatment Development Restore Medical Ltd., an emerging player in the medical device sector, is making significant strides in its clinical pathway for a groundbr…
Restore Medical's Strategic Leadership Appointment Signals Advancements in Heart Failure Treatment Restore Medical Ltd., a privately held medical device company based in Or-Yehuda, Israel, is making s…
Medtronic's Strong Financial Performance and Strategic Innovations Signal Resilience in Healthcare Medtronic Plc announces impressive financial results for the second quarter of 2026, demonstrating ro…
Medtronic's Strategic Growth in Medical Technology Medtronic plc (NYSE: MDT) demonstrates strong momentum in the healthcare technology sector, as evidenced by its financial results for the second quar…
Medtronic Prepares for Crucial Q2 Fiscal Results Amidst Industry Challenges As Medtronic Plc gears up to announce its second-quarter fiscal year 2026 results on November 18, the medical devices giant…
Medtronic's Landmark SPYRAL Trial Results Reinforce Efficacy of Symplicity RDN Procedure Medtronic plc, a leader in healthcare technology, unveils promising long-term results from its SPYRAL HTN-ON ME…
Medtronic’s Breakthrough in Hypertension Treatment: Long-Term Efficacy of Symplicity™ Spyral RDN Procedure Medtronic plc, a leader in global healthcare technology, announces compelling long-term resul…
Medtronic's Competitive Landscape: Insights from Boston Scientific's Upcoming Earnings As the medical technology sector continues to evolve, companies like Medtronic Plc closely monitor the competitiv…
Strategic Growth Initiatives in Medical Technology: Boston Scientific's Upcoming Earnings Report As Boston Scientific prepares to release its quarterly earnings report on October 22, 2025, the focus s…